| Targeting MEK in a translational model of histiocytic sarcoma M Takada, JML Hix, S Corner, PZ Schall, M Kiupel, V Yuzbasiyan-Gurkan Molecular cancer therapeutics 17 (11), 2439-2450, 2018 | 30 | 2018 |
| Gain‐of‐function mutation in PTPN11 in histiocytic sarcomas of Bernese Mountain Dogs T Thaiwong, S Sirivisoot, M Takada, V Yuzbasiyan‐Gurkan, M Kiupel Veterinary and comparative oncology 16 (2), 220-228, 2018 | 29 | 2018 |
| Activating mutations in PTPN11 and KRAS in canine histiocytic sarcomas M Takada, LA Smyth, T Thaiwong, M Richter, SM Corner, PZ Schall, ... Genes 10 (7), 505, 2019 | 21 | 2019 |
| Dynamic Contrast–Enhanced MRI of OATP Dysfunction in Diabetes DD Shuboni-Mulligan, M Parys, B Blanco-Fernandez, CL Mallett, ... Diabetes 68 (2), 271-280, 2019 | 16 | 2019 |
| Prostate cancer characterization by optical contrast enhanced photoacoustics G Xu, M Qin, A Mukundan, J Siddiqui, M Takada, P Vilar-Saavedra, ... Photons Plus Ultrasound: Imaging and Sensing 2016 9708, 97080I, 2016 | 16 | 2016 |
| A novel canine histiocytic sarcoma cell line: initial characterization and utilization for drug screening studies M Takada, M Parys, E Gregory-Bryson, PV Saavedra, M Kiupel, ... BMC cancer 18 (1), 1-13, 2018 | 13 | 2018 |
| Investigation of novel chemotherapeutics for feline oral squamous cell carcinoma HJ Piegols, M Takada, M Parys, T Dexheimer, V Yuzbasiyan-Gurkan Oncotarget 9 (69), 33098, 2018 | 12 | 2018 |
| Development of an Orthotopic Intrasplenic Xenograft Mouse Model of Canine Histiocytic Sarcoma and Its Use in Evaluating the Efficacy of Treatment with Dasatinib M Takada, LA Smyth, JML Hix, SM Corner, M Kiupel, ... Comparative medicine 69 (1), 22-28, 2019 | 9 | 2019 |
| A novel canine histiocytic sarcoma cell line provides a potential path to effective treatments with relevance for translational and comparative studies in humans M Takada, M Parys, E Gregory-Bryson, V Yuzbasiyan-Gurkan Cancer Research 74 (19 Supplement), 3931-3931, 2014 | 4 | 2014 |
| Definitive‐intent radiotherapy for sinonasal carcinoma in cats: a multicenter retrospective assessment K Stiborova, VS Meier, M Takada, M Turek, VJ Poirier, S Laliberte, ... Veterinary and comparative oncology 18 (4), 626-633, 2020 | 3 | 2020 |
| Identification of a Hypomorphic FANCG Variant in Bernese Mountain Dogs K Meek, YT Yang, M Takada, M Parys, M Richter, AI Engleberg, ... Genes 13 (10), 1693, 2022 | 1 | 2022 |
| Dasatinib displays antitumor efficacy in an orthotopic xenograft mouse model of histiocytic sarcoma M Takada, L Smyth, V Yuzbasiyan-Gurkan Cancer Research 78 (13 Supplement), 2166-2166, 2018 | | 2018 |
| Histiocytic Sarcoma: Generation and Utilization of Patient Derived Cell Lines and Xenograft Models to Understand Tumorigenesis and Identify Novel Treatment Approaches M Takada Michigan State University. Comparative Medicine and Integrative Biology, 2018 | | 2018 |
| Detection of circulating tumor cells in osteosarcoma: A validation study using a translational model M Takada, YT Yang, H Piegols, PV Saavedra, CM Tang, P Amstutz, ... Cancer Research 77 (13 Supplement), 3921-3921, 2017 | | 2017 |
| Abstract B46: Evaluation of JQ1 as a cytotoxic agent in canine sarcoma cell lines YT Yang, M Takada, V Yuzbasiyan-Gurkan Molecular Cancer Research 13 (10 Supplement), B46-B46, 2015 | | 2015 |
| Evaluation of Therapeutic Response of Histiocytic Sarcoma Cell Lines to Novel Small Molecule Inhibitors of Receptor Tyrosine Kinases M Takada Michigan State University. Small Animal Clinical Sciences, 2013 | | 2013 |
